Faculty Information - TSURUTA Yuuki

（Last updated : 2024-03-26 13:43:55）

TSURUTA Yuuki
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Internal Medicine, Division of Nephrology

Position

■ Published papers

1.	Original article	Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study 2022/03/08
2.	Original article	Glycated albumin is a better indicator of the glucose excursion than predialysis glucose and hemoglobin A1c in hemodialysis patients 2016/02
3.	Original article	Eicosapentaenoic Acid (EPA) Decreases the All-Cause Mortality in Hemodialysis Patients 2015/12/15
4.	Original article	Febuxostat improves endothelial function in hemodialysis patients with hyperuricemia: A randomized controlled study. 2015/10
5.	Original article	Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease. 2014/11
6.	Original article	Association between allopurinol and mortality among Japanese hemodialysis patients: results from the DOPPS. 2014/09
7.	Original article	Long-term damage assessment in patients with microscopic polyangiitis and renal-limited vasculitis using the Vasculitis Damage Index. 2014/01
8.	Original article	Effests of cinacalcet on bone mineral density and bone markers in hemodialysis patients with secondary hyperparathyroidism 2013/02
9.	Original article	Positive C1q staining associated with poor renal outcome in membranoproliferative glomerulonephritis. 2013/02
10.	Original article	Oxidised LDL/LDL-cholesterol ratio and coronary artery calcification in haemodialysis patients 2013
11.	Original article	Severity of nephrotic IgA nephropathy according to the Oxford classification. 2012/08
12.	Original article	Comparison of inhibitors of renin-angiotensin-aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function. 2012/04
13.	Original article	Beneficial effect of aliskiren combined with olmesartan in reducing urinary protein excretion in patients with chronic kidney disease. 2012
14.	Case report	Rituximab Treatment for Adult Patients with Focal Segment Glimerulosclerosis 2012
15.	Original article	Ritsuximab treatment for adult patients with focus segmental glomerulosclerosis 2011/12
16.	Original article	Correlation of new bone metabolic markers with conventional biomarkers in hemodialysis patients. 2011/10
17.	Original article	Comparison of Steroids and Angiotensin Receptor Blockers for Patients with Advanced IgA Nephropathy and Impaired Renal Function 2011
18.	Original article	Long-term beneficial effects of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy for patients with advanced immunoglobulin A nephropathy and impaired renal function. 2011
19.	Original article	The significance of caveolae in the glomeruli in glomerular disease 2011
20.	Original article	Cardiovascular autonomic neuropathy studied by a laser-Dopplaer blood flowmeter in hemodialysis patients. 2010
21.	Original article	Effect of Single-Dose Rituximab on Primary Glomerular Diseases. 2010
22.	Original article	Phosphorylation status of nephrin in human membranous nephropathy 2010
23.	Original article	Suppression of renal fibrosis by galectin-1 in high glucose-treated renal epithelial cells. 2010
24.	Original article	Antiphospholipid antibodies and renal outcomes in patients with lupus nephritis 2009
Display 5 items
Display all(24)

■ Academic conference presentation

1.	Development of an Automatic Risk-Prediction System for Hemodialysis Patients Using Artificial Inteligence: A Nationwide Dialysis Cohort Study in Japan （Speech，Panelist at Symposium/Workshop (Applied)） 2019/11/09
2.	SERUM LEVELS OF OSTEOCALCIN ARE ASSOCIATED WITH CEREBRAL AND CARDIAC VASCULAR DISEASES IN HEMODIALYSIS PATIENTS （Poster notice，General） 2013/05/20
3.	EICOSAPENTAENOIC ACID (EPA) IS AN INDEPENDENT PREDICTOR OF ALL-CAUSE MORTALITY IN HEMODIALYSIS PATIENTS （Poster notice，General） 2013/05/19
4.	Effect of Cinacalcet on the Change of Bone Mineral Density and Bone Markers in Hemodialysis Patients with Secondary Hyperparathyroidism （General） 2010/11
5.	Allopurinol and all-cause mortality among hemodialysis(HD) patients(PTS) : Results from the dialysis outcomes and practice patients （General） 2010/06